BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7817583)

  • 21. Acute acalculous cholecystitis in juvenile systemic lupus erythematosus.
    Mendonça JA; Marques-Neto JF; Prando P; Appenzeller S
    Lupus; 2009 May; 18(6):561-3. PubMed ID: 19395459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Favourable interactions of cytostatic and steroid drugs in treatment of systemic lupus erythematosus.
    Wiewiórowski M; Graczyk J
    Acta Pol Pharm; 2000 Nov; 57 Suppl():92-5. PubMed ID: 11293279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ocular tuberculosis in systemic lupus erythematosus and immunosuppressive therapy].
    Anders N; Wollensak G
    Klin Monbl Augenheilkd; 1995 Dec; 207(6):368-71. PubMed ID: 8583748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient monthly oral bolus cyclophosphamide therapy in systemic lupus erythematosus.
    Dawisha SM; Yarboro CH; Vaughan EM; Austin HA; Balow JE; Klippel JH
    J Rheumatol; 1996 Feb; 23(2):273-8. PubMed ID: 8882031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis.
    Schmaldienst S; Jansen M; Hollenstein U; Graninger W; Regele H; Hörl WH; Derfler K
    Am J Kidney Dis; 2002 Feb; 39(2):415-8. PubMed ID: 11840385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central nervous system manifestations in juvenile systemic lupus erythematosus: a problem of management.
    Davies UM; Ansell BM
    J Rheumatol; 1988 Nov; 15(11):1720-1. PubMed ID: 3236306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
    Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morphological and immunohistochemical changes in the kidneys and skin in systemic lupus erythematosus during the course of treatment].
    Gritsman NN; Akhnazarova VD; Ivanova MM; Solov'ev SK
    Revmatologiia (Mosk); 1983; (2):41-5. PubMed ID: 6353514
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of high doses of glucocorticoids in patients with rheumatic diseases].
    Dormidontov EN; Korshunov NI; Baranova EIa; Zheltkevich SN; Razumova EB
    Ter Arkh; 1985; 57(8):12-6. PubMed ID: 4071425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Narcolepsy associated with systemic lupus erythematosus].
    Haddad F; Anouti S; Maalouly G; Koussa S
    Rev Med Interne; 2011 Nov; 32(11):e114-5. PubMed ID: 21145142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association of systemic lupus erythematosis and myasthenia gravis. A new case report].
    Louzir B; Ben Abdelhafidh N; Bahri M; M'Sadek F; Ksontini I; Boussema E; Othmani S
    Tunis Med; 2003 Dec; 81(12):963-6. PubMed ID: 14986533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pneumatosis cystoides intestinalis associated with intravenous pulse cyclophosphamide treatment for systemic lupus erythematosus].
    Nonaka D; Higuchi M; Yoshizawa S; Horiuchi T; Nakashima H; Niho Y
    Ryumachi; 1998 Aug; 38(4):605-10. PubMed ID: 9785989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute transverse myelitis in systemic lupus erythematosus: a case of rapid diagnosis and complete recovery.
    Habr F; Wu B
    Conn Med; 1998 Jul; 62(7):387-90. PubMed ID: 9707792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The one-and-a-half syndrome in systemic lupus erythematosus.
    Yiğit A; Bingöl A; Mutluer N; Taşçilar N
    J Neuroophthalmol; 1996 Dec; 16(4):274-6. PubMed ID: 8956164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intravenous administration of high doses (pulse therapy) of methylprednisolone in lupus nephritis].
    Ivanova MM; Solov'ev SK; Speranskiĭ AI; Nasonov EL
    Ter Arkh; 1983; 55(7):114-9. PubMed ID: 6623376
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cyclosporin therapy of patients with systemic lupus erythematosus].
    Gergely P
    Orv Hetil; 1994 Nov; 135(47):2591-5. PubMed ID: 7824258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Remote results of combined immunosuppressive treatment of systemic lupus erythematosus (1969-1978)].
    Wysocka K; Kiczak J; Hawrlylak E
    Wiad Lek; 1979 Nov; 32(22):1591-4. PubMed ID: 538910
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus.
    Nikolov NP; Smith JA; Patronas NJ; Illei GG
    Nat Clin Pract Rheumatol; 2006 Nov; 2(11):627-33; quiz 634. PubMed ID: 17075602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.